Company news

PainChek Ltd news in 2025

PainChek Ltd's news releases, calls and decks from 2025, newest first.

View company

AGM Presentation

November 25, 2025

Investor Presentation

October 30, 2025

Notice of Annual General Meeting/Proxy Form

October 24, 2025

Key hire to drive Infant App in $15Bn addressable market

October 16, 2025

Response to ASX Aware Letter

October 16, 2025

PainChek Secures First US Customer Following FDA Clearance

October 12, 2025

PainChek FDA Cleared to Commence Sales in US$100M US Market

October 8, 2025

Trading Halt

October 6, 2025

Compelling Clinical and Economic Results in Scottish Pilot

September 16, 2025

Preliminary Final Report

August 28, 2025

Strongly Supported A$7.5m Placement to Drive Int. Growth

July 28, 2025

Final US FDA De Novo Clearance Submission Completed

July 20, 2025

PainChek Reports Strong Quarterly Sales Growth

July 2, 2025

PainChek has productive final FDA De Novo clearance meeting

June 4, 2025

PainChek partners with Eldermark to expand US market reach

May 26, 2025

R&D Tax Refund, FDA Review of Adult App & Infant App Launch

April 15, 2025

Decks in 2025